Volume | 664,799 |
|
|||||
News | - | ||||||
Day High | 1.99 | Low High |
|||||
Day Low | 1.79 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
GlycoMimetics Inc | GLYC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.99 | 1.79 | 1.99 | 1.855 | 1.835 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,300 | 664,799 | $ 1.86 | $ 1,234,579 | - | 1.11 - 3.5299 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:57:05 | formt | 100 | $ 1.8889 | USD |
GlycoMimetics (GLYC) Options Flow Summary
GlycoMimetics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
119.13M | 64.39M | - | 10k | -36.9M | -0.57 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
GlycoMimetics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLYC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.16 | 2.39 | 1.74 | 1.96 | 1,119,502 | -0.2711 | -12.55% |
1 Month | 2.91 | 3.18 | 1.74 | 2.39 | 742,278 | -1.02 | -35.09% |
3 Months | 3.40 | 3.47 | 1.74 | 2.65 | 452,947 | -1.51 | -44.44% |
6 Months | 1.15 | 3.5299 | 1.11 | 2.58 | 343,020 | 0.7389 | 64.25% |
1 Year | 1.45 | 3.5299 | 1.11 | 2.28 | 257,882 | 0.4389 | 30.27% |
3 Years | 2.54 | 4.16 | 0.51 | 2.11 | 434,488 | -0.6511 | -25.63% |
5 Years | 13.01 | 13.41 | 0.51 | 3.05 | 473,225 | -11.12 | -85.48% |
GlycoMimetics Description
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. |